Matthew Teltser: Final Debarment Order
Published Date: 2/6/2026
Notice
Summary
Matthew Teltser is permanently banned from working with any company that has drug products approved or waiting for approval because he was convicted of a serious crime related to drug development. He didn’t respond to the FDA’s notice, so the ban started on February 6, 2026. He can apply to end this ban anytime, but it won’t be easy or quick.
Analyzed Economic Effects
5 provisions identified: 1 benefits, 3 costs, 1 mixed.
Civil Penalties for Employers Who Hire Debarred Person
Any person with an approved or pending drug product application who knowingly employs, retains as a consultant or contractor, or otherwise uses the services of Matthew Teltser during his period of debarment will be subject to civil money penalties under section 307(a)(6) of the FD&C Act. The debarment period began February 6, 2026.
Individual Penalties for Providing Services During Debarment
If Matthew Teltser provides services in any capacity to a person with an approved or pending drug product application during his debarment, he will be subject to civil money penalties under section 307(a)(7) of the FD&C Act. The debarment is effective February 6, 2026.
FDA Will Not Accept ANDAs From Debarred Individual
During his period of debarment, FDA will not accept or review any abbreviated new drug application (ANDA) from Matthew Teltser, except in connection with an audit under section 306 of the FD&C Act. This restriction began on February 6, 2026.
Permanent FDA Debarment Effective Feb 6, 2026
The FDA permanently debarred Matthew Teltser from providing services in any capacity to a person that has an approved or pending drug product application, effective February 6, 2026. The debarment follows his June 10, 2025 federal conviction for making a false statement and his failure to request a hearing after receiving FDA's notice on September 8, 2025.
Right to Apply for Special Termination; Public Filing Rules
Dr. Teltser may apply at any time for special termination of debarment under section 306(d)(4) of the FD&C Act. Applications submitted electronically to https://www.regulations.gov will be posted publicly unless submitted as a written/paper confidential submission following FDA's instructions.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16714, Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food
The Food and Drug Administration (FDA or the Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's third-party disclosure and recordkeeping requirements for reportable food.
2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries
The FDA wants your thoughts on how they collect info about imports and electronic import entries. If you’re involved in importing goods, this could affect you! They’re asking for comments by October 16, 2026, to help improve the process without adding extra costs or hassle.
2026-16715, Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Previous / Next Documents
Previous: 2026-02348, Procurement List; Additions and Deletions
Starting March 8, 2026, some services will be added to the government’s special shopping list, meaning nonprofit groups that help people who are blind or severely disabled will get new contracts. At the same time, a few products will be removed from that list. These changes help support great causes without adding extra costs or paperwork for small businesses.
Next: 2026-02351, Agency Information Collection Activities; Extension; International Mail Duty Worksheet (IMDW)
U.S. Customs and Border Protection is extending the use of the International Mail Duty Worksheet (IMDW), which helps track duties on international mail. This extension means businesses and mail handlers will keep using the same form, with no new costs or changes. You’ve got until March 9, 2026, to share your thoughts or questions about this paperwork.